Literature DB >> 29579766

How Should Lungs Be Allocated for Transplant?

Thomas M Egan1,2.   

Abstract

As lung transplantation became established therapy for end-stage lung disease, there were not nearly enough suitable lungs from brain-dead organ donors to meet the need, leading to a focus on how lungs are allocated for transplant. Originally lungs were allocated by the United Network for Organ Sharing (UNOS) like hearts-by waiting time, first to listed recipients in the organ procurement organization of the donor, then to potential recipients in concentric 500 nautical mile circles. This resulted in long waiting times and increasing waitlist deaths. In 1999, the Health Resources and Services Administration published a Final Rule, requesting UNOS to review organ allocation algorithms to ensure that they complied with the desire to allocate organs based on urgency, avoiding futile transplants, and minimizing the role of waiting time in organ allocation. This led to development of the lung allocation score (LAS), which allocates lungs based on urgency and transplant benefit, introduced in 2005. The U.S. LAS system was adopted by Eurotransplant to allocate unused lungs between donor countries, and by both Germany and the Netherlands for lung allocation in their countries. This article will review the history of lung allocation, discuss the impact of LAS and its shortcomings, suggest recommendations to increase the number of lungs for transplant, and improve allocation of donated lungs. Ultimately, the goal of organ transplant research is to have so many organs to transplant that allocation systems are unnecessary. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29579766     DOI: 10.1055/s-0037-1620265

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  8 in total

1.  Which Shall I Choose? Lung Transplantation Listing Preference for Individuals with Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Kathleen J Ramos; Michael O Harhay; Michael S Mulligan
Journal:  Ann Am Thorac Soc       Date:  2019-02

2.  Post-COVID-19 Lung Transplantation Italian Pivotal Protocol: Some Ethical Considerations.

Authors:  C Petrini; D Peritore; L Riva; G Floridia; S Gainotti; P A Grossi; A G Castiglione; M Beretta; F Rea; M Nosotti; L Lombardini; M Cardillo
Journal:  Transplant Proc       Date:  2022-06-01       Impact factor: 1.014

3.  Low body mass index as a barrier to lung transplant in cystic fibrosis.

Authors:  Ann L Jennerich; Joseph B Pryor; Travis Y Hee Wai; Siddhartha G Kapnadak; Moira L Aitken; Christopher H Goss; Kathleen J Ramos
Journal:  J Cyst Fibros       Date:  2021-12-23       Impact factor: 5.527

4.  Donor Lung Sequence Number and Survival after Lung Transplantation in the United States.

Authors:  Michael O Harhay; Raphaël Porcher; Gabriel Thabut; Michael J Crowther; Thomas DiSanto; Samantha Rubin; Zachary Penfil; Zhou Bing; Jason D Christie; Joshua M Diamond; Edward Cantu
Journal:  Ann Am Thorac Soc       Date:  2019-03

5.  Geographic disparities in lung transplantation in the United States before and after the November 2017 allocation change.

Authors:  Luke J Benvenuto; Michaela R Anderson; Meghan Aversa; Mark E Snyder; Hilary Robbins; Lori Shah; Harpreet Singh Grewal; David Anderson; Joseph Costa; Brian P Stanifer; Philippe Lemaitre; Joshua R Sonett; Frank D'Ovidio; Selim M Arcasoy
Journal:  J Heart Lung Transplant       Date:  2021-11-15       Impact factor: 13.569

Review 6.  The new allocation era and policy.

Authors:  Luke J Benvenuto; Selim M Arcasoy
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

Review 7.  Lung transplantation: a review of the optimal strategies for referral and patient selection.

Authors:  Alicia B Mitchell; Allan R Glanville
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 8.  Timing it right: the challenge of recipient selection for lung transplantation.

Authors:  Henry W Ainge-Allen; Allan R Glanville
Journal:  Ann Transl Med       Date:  2020-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.